CD34 and FSHR Expression to Differentiate Multiple Subtypes of Benign and Malignant Renal Neoplasms

BackgroundCurrently, no markers accurately differentiate benign from malignant renal masses. CD34 and FSHR are transmembrane proteins involved in neo-angiogenetic pathways and are differently expressed in several normal and cancerous tissues. However, little evidence exists on their distribution in...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Giancarlo Marra, Didier Meseure, Marine Lefèvre, Andre Nicolas, Laetitia Lesage, Nicolae Ghinea, Marco Moschini, Caio Pasquali, Petr Macek, Claudia Filippini, Paolo Gontero, Rafael Sanchez-Salas, Xavier Cathelineau
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	MDPI AG 2022-05-01
Schriftenreihe:	Société Internationale d’Urologie Journal
Schlagworte:	kidney cancer cd34 fshr tumor markers
Online-Zugang:	https://siuj.org/index.php/siuj/article/view/183/115
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!